Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Pregnancy outcomes after maternal betahistine exposure: A case series.

Buharalioglu CK, Acar S, Erol-Coskun H, Küçüksolak G, Karadas B, Kaya-Temiz T, Kaplan YC.

Reprod Toxicol. 2018 Aug;79:79-83. doi: 10.1016/j.reprotox.2018.06.004. Epub 2018 Jun 13.

PMID:
29908288
2.

Pregnancy outcomes after maternal use of thiocolchicoside: A case series.

Kaplan YC, Keskin-Arslan E, Küçüksolak G, Akyol F, Karadas B, Görgel SN, Kaya-Temiz T.

Reprod Toxicol. 2018 Mar;76:103-108. doi: 10.1016/j.reprotox.2018.01.003. Epub 2018 Jan 31.

PMID:
29378258
3.

Comment on "Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study" by Muanda et al.

Acar S, Erol-Coskun H, Kaplan YC.

Br J Clin Pharmacol. 2018 May;84(5):1081-1082. doi: 10.1111/bcp.13484. Epub 2018 Jan 6. No abstract available.

PMID:
29315713
4.

Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services.

Panchaud A, Rousson V, Vial T, Bernard N, Baud D, Amar E, De Santis M, Pistelli A, Dautriche A, Beau-Salinas F, Cassina M, Dunstan H, Passier A, Kaplan YC, Duman MK, Maňáková E, Eleftheriou G, Klinger G, Winterfeld U, Rothuizen LE, Buclin T, Csajka C, Hernandez-Diaz S.

Br J Clin Pharmacol. 2018 Mar;84(3):568-578. doi: 10.1111/bcp.13481. Epub 2018 Jan 14.

PMID:
29215149
5.

Maternal β-Blocker Use and Fetal Cardiac Anomalies.

Keskin-Arslan E, Akoz A, Kaplan YC.

JAMA Intern Med. 2017 Nov 1;177(11):1692. doi: 10.1001/jamainternmed.2017.4894. No abstract available.

PMID:
29114787
6.

Evaluation of the neuropathic pain in the smokers.

Çelik SB, Can H, Sözmen MK, Şengezer T, Kaplan YC, Utlu G, Şener A, Aybek Yılmaz A, Aygün O.

Agri. 2017 Jul;29(3):122-126. doi: 10.5505/agri.2017.68815.

7.

Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.

Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K.

Br J Clin Pharmacol. 2017 Dec;83(12):2798-2806. doi: 10.1111/bcp.13382. Epub 2017 Aug 27. Review.

PMID:
28734011
8.

Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey.

Kaplan YC, Karadaş B, Küçüksolak G, Ediz B, Demir Ö, Sozmen K, Nordeng H.

Int J Clin Pharm. 2017 Aug;39(4):783-790. doi: 10.1007/s11096-017-0496-5. Epub 2017 Jun 19.

PMID:
28626851
9.

Teicoplanin Use During Breastfeeding.

Kaplan YC, Keskin-Arslan E, Acar S, Erol-Coskun H.

Breastfeed Med. 2017 Mar;12:124. doi: 10.1089/bfm.2016.0186. Epub 2017 Jan 4. No abstract available.

PMID:
28051878
10.

Comment on the case report "Possible association between acetazolamide administration during pregnancy and multiple congenital malformations".

Keskin-Arslan E, Kaplan YC.

Drug Des Devel Ther. 2016 Nov 10;10:3681-3683. eCollection 2016. No abstract available.

11.

Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services.

Richardson JL, Stephens S, Yates LM, Diav-Citrin O, Arnon J, Beghin D, Kayser A, Kennedy D, Cupitt D, Te Winkel B, Peltonen M, Kaplan YC, Thomas SH.

Reprod Toxicol. 2017 Jan;67:26-34. doi: 10.1016/j.reprotox.2016.11.010. Epub 2016 Nov 13.

PMID:
27851994
12.

Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.

Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K.

Reprod Toxicol. 2016 Dec;66:31-43. doi: 10.1016/j.reprotox.2016.09.013. Epub 2016 Sep 22. Review.

PMID:
27667009
13.

Effect of nitrergic system on colonic motility in a rat model of irritable bowel syndrome.

Temiz TK, Demir O, Simsek F, Kaplan YC, Bahceci S, Karadas B, Celik A, Koyluoglu G.

Indian J Pharmacol. 2016 Jul-Aug;48(4):424-429.

14.

Comment on "Identifying Human Teratogens: An Update".

Kaplan YC.

J Pediatr Genet. 2016 Sep;5(3):181-2. doi: 10.1055/s-0036-1584308. Epub 2016 Jun 1. No abstract available.

15.

Valproate prescribing trends for non-epilepsy indications in women of reproductive age warrants effective measures and increased surveillance.

Kaplan YC, Abdelkader N.

Seizure. 2016 Aug;40:13-4. doi: 10.1016/j.seizure.2016.05.007. Epub 2016 May 24. No abstract available.

16.

Prenatal Antidepressant Use and Risk of Autism Spectrum Disorders in Children.

Kaplan YC, Keskin-Arslan E, Acar S.

JAMA Pediatr. 2016 Jul 1;170(7):712. doi: 10.1001/jamapediatrics.2016.0727. No abstract available.

PMID:
27244647
17.

Folic acid, body mass index and cardiovascular malformations.

Kaplan YC, Küçüksolak G.

Turk Pediatri Ars. 2016 Mar 1;51(1):60-1. doi: 10.5152/TurkPediatriArs.2016.3324. eCollection 2016 Mar. No abstract available.

18.

Comment on the case report "Limb deformity in a newborn. Is rifampicin just an innocent bystander?" by Kalayci et al.

Keskin-Arslan E, Acar S, Kaplan YC.

Eur Rev Med Pharmacol Sci. 2016;20(1):1-2. No abstract available.

19.

Fluconazole use during breastfeeding.

Kaplan YC, Koren G, Ito S, Bozzo P.

Can Fam Physician. 2015 Oct;61(10):875-6.

20.

Comment to the article 'Use of psychotropic drugs during pregnancy and breast-feeding'.

Kaplan YC, Spigset O.

Acta Psychiatr Scand. 2016 May;133(5):428-9. doi: 10.1111/acps.12547. Epub 2016 Jan 4. No abstract available.

PMID:
26727540
21.

Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.

Kaplan YC, Ozsarfati J, Nickel C, Koren G.

Br J Clin Pharmacol. 2016 May;81(5):835-48. doi: 10.1111/bcp.12872. Epub 2016 Feb 16. Review.

22.

Comment on: "Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India".

Yöntem S, Maden-Tastan B, Kaplan YC.

Drug Saf. 2016 Jan;39(1):89-90. doi: 10.1007/s40264-015-0355-z. No abstract available.

PMID:
26507883
23.

Fluconazole exposure during pregnancy.

Kaplan YC, Koren G, Bozzo P.

Can Fam Physician. 2015 Aug;61(8):685-6.

24.

Dose-Dependent Risk of Malformations With Antiepileptic Drugs: An Analysis of Data From the EURAP Epilepsy and Pregnancy Registry.

Kaplan YC, Nulman I, Koren G.

Ther Drug Monit. 2015 Oct;37(5):557-8. doi: 10.1097/FTD.0000000000000193. No abstract available.

PMID:
26378370
25.

Response to "Congenital microtia in a neonate suspected of isotretinoin exposure one month before pregnancy: A case report".

Kaplan YC, Karadaş B, Kaya-Temiz T.

J Obstet Gynaecol Res. 2015 Dec;41(12):2008-9. doi: 10.1111/jog.12812. Epub 2015 Aug 26. No abstract available.

PMID:
26310204
26.

Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.

Kaplan YC, Ozsarfati J, Etwel F, Nickel C, Nulman I, Koren G.

Br J Dermatol. 2015 Nov;173(5):1132-41. doi: 10.1111/bjd.14053. Epub 2015 Oct 19. Review.

PMID:
26215715
27.

Drug use and/or exposure in pregnancy: Presence of risk versus quantity of risk.

Kaplan YC.

J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):123. doi: 10.5152/jtgga.2015.15031. eCollection 2015. No abstract available.

28.

Use of ciprofloxacin during breastfeeding.

Kaplan YC, Koren G.

Can Fam Physician. 2015 Apr;61(4):343-4. Review.

29.

Defining a medication class as a teratogen: may the evidence be with you and not the FDA Pregnancy Risk Categories.

Kaplan YC, Karadaş B, Kaya-Temiz T.

Acad Emerg Med. 2015 Jun;22(6):769. doi: 10.1111/acem.12691. Epub 2015 May 21. No abstract available.

30.

In utero exposure to methotrexate and risk of congenital malformations.

Damkier P, Kaplan YC.

Am J Med Genet A. 2015 Oct;167A(10):2488-9. doi: 10.1002/ajmg.a.37153. Epub 2015 May 5. No abstract available.

PMID:
25943497
31.

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE.

J Clin Psychopharmacol. 2015 Jun;35(3):250-9. doi: 10.1097/JCP.0000000000000309.

PMID:
25830592
32.

Exposure to fluconazole and risk of congenital malformations in the offspring: A systematic review and meta-analysis.

Alsaad AM, Kaplan YC, Koren G.

Reprod Toxicol. 2015 Apr;52:78-82. doi: 10.1016/j.reprotox.2015.02.009. Epub 2015 Feb 25. Review.

PMID:
25724389
33.

Congenital Mydriasis: Diagnostic Challenge in a Case with Accompanying Neurologic Symptoms.

Atik S, Koc F, Kaplan YC, Yurtseven SG.

Neuroophthalmology. 2014 Apr 25;38(3):153-155. eCollection 2014.

34.

Pregnancy outcome after varenicline exposure in the first trimester.

Kaplan YC, Olgac Dündar N, Kasap B, Karadas B.

Case Rep Obstet Gynecol. 2014;2014:263981. doi: 10.1155/2014/263981. Epub 2014 Feb 3.

35.
36.

Protective effect of an adenosine A1 receptor agonist against metamidophos-induced toxicity and brain oxidative stress.

Kalkan S, Ozdemir D, Ergur BU, Hazardin NU, Akgun A, Topcu A, Kaplan YC, Hocaoglu N, Oransay K, Tuncok Y.

Toxicol Mech Methods. 2009 Feb;19(2):148-53. doi: 10.1080/15376510802355141.

PMID:
19778260
37.

Effects of acute and subacute garlic supplement administration on serum total antioxidant capacity and lipid parameters in healthy volunteers.

Koseoglu M, Isleten F, Atay A, Kaplan YC.

Phytother Res. 2010 Mar;24(3):374-8. doi: 10.1002/ptr.2953.

PMID:
19653315
38.

Effect of glucagon on amitriptyline-induced cardiovascular toxicity in rats.

Kaplan YC, Hocaoglu N, Oransay K, Kalkan S, Tuncok Y.

Hum Exp Toxicol. 2008 Apr;27(4):321-5. doi: 10.1177/0960327108092289.

PMID:
18684803
39.

Effect of subacute methyl parathion administration on the pharmacokinetics and pharmacodynamics of nifedipine in rats.

Gelal A, Eminoglu O, Kaplan YC, Kalkan S.

Environ Toxicol Pharmacol. 2007 Jul;24(1):1-4. doi: 10.1016/j.etap.2006.11.010. Epub 2006 Dec 9.

PMID:
21783781
40.

Efficacy of an adenosine A1 receptor agonist compared with atropine and pralidoxime in a rat model of organophosphate poisoning.

Kalkan S, Ergur BU, Akgun A, Kaplan YC, Kinay AO, Tuncok Y.

Hum Exp Toxicol. 2005 Jul;24(7):369-75.

PMID:
16119251
41.

Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.

Gelal A, Balkan D, Ozzeybek D, Kaplan YC, Gurler S, Guven H, Benowitz NL.

Eur J Clin Pharmacol. 2005 Jan;60(11):785-90. Epub 2004 Dec 11.

PMID:
15592925

Supplemental Content

Loading ...
Support Center